Royal Marsden NHS Foundation Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.royalmarsden.nhs.uk

Clinical Trials

Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer

Not Applicable

Completed

Conditions: Colorectal Cancer
Fallopian Tube Cancer
Sarcoma
Radiation Toxicity
Bladder Cancer
Cervical Cancer
Ovarian Cancer
Anal Cancer
Gastrointestinal Complications

First Posted Date: 2010-07-27

Last Posted Date: 2016-11-01

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 177

Registration Number: NCT01170299

Locations: 🇬🇧
Royal Marsden - London, London, England, United Kingdom

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Phase 3

Conditions: Bladder Cancer
Cervical Cancer
Colorectal Cancer
Endometrial Cancer
Gastrointestinal Complications
Long-term Effects Secondary to Cancer Therapy in Adults
Ovarian Cancer
Prostate Cancer
Radiation Toxicity
Sarcoma

First Posted Date: 2010-03-16

Last Posted Date: 2011-07-15

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 75

Registration Number: NCT01087268

Locations: 🇬🇧
Royal Marsden - Surrey, Sutton, England, United Kingdom

A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)

Phase 2

Terminated

Conditions: Pancreatic Cancer

Interventions: Other: UFT/ Leucovorin + Cetuximab + Radiotherapy
Other: UFT, Leucovorin

First Posted Date: 2010-01-15

Last Posted Date: 2016-10-14

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 17

Registration Number: NCT01050426

Locations: 🇬🇧
Poole Hospital NHS Trust, Poole, United Kingdom
🇬🇧
Aberdeen Royal Infirmary, Aberdeen, United Kingdom
🇬🇧
Kent Oncology Centre, Tunbridge Wells, Maidstone, United Kingdom

and more 5 locations

Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy

Phase 2

Conditions: Rectal Adenocarcinoma

First Posted Date: 2010-01-13

Last Posted Date: 2019-06-13

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 99

Registration Number: NCT01047969

Locations: 🇬🇧
Royal Marsden NHS Foundation Trust, London, United Kingdom

Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer

Phase 1

Completed

Conditions: Advanced Pancreatic Cancer

Interventions: Drug: Gemcitabine
Drug: Oxaliplatin
Drug: Imatinib

First Posted Date: 2010-01-13

Last Posted Date: 2012-09-25

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 36

Registration Number: NCT01048320

Locations: 🇬🇧
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

Partial Liver Radiotherapy for Unresectable Liver Metastases

Not Applicable

Conditions: Metastatic Colorectal Liver Cancer

First Posted Date: 2010-01-13

Last Posted Date: 2010-01-13

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 18

Registration Number: NCT01048216

Locations: 🇬🇧
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Phase 2

Conditions: Adenocarcinoma
Adenocarcinoma, Mucinous
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Cystic, Mucinous, and Serous
Digestive System Neoplasms
Intestinal Diseases
Carcinoma
Colorectal Neoplasms
Digestive System Diseases

Interventions: Other: Patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapy

First Posted Date: 2009-12-21

Last Posted Date: 2018-09-17

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 237

Registration Number: NCT01037049

Locations: 🇬🇧
Poole Hospital NHS Foundation Trust, Poole, Dorset, United Kingdom
🇧🇷
Hospital Alemão Oswaldo Cruz, Sao Paulo, Brazil
🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada

and more 20 locations

Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting

Completed

Conditions: Sarcoma
Melanoma

First Posted Date: 2009-12-17

Last Posted Date: 2016-05-23

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 250

Registration Number: NCT01034696

Locations: 🇬🇧
Royal Marsden Hospital, Sutton, Surrey, United Kingdom

Evaluation of Bladder Volumes in Patients Receiving Radiotherapy to the Rectum, Using Kilovoltage Cone-beam Imaging

Conditions: Rectal Cancer

First Posted Date: 2009-12-16

Last Posted Date: 2009-12-16

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 10

Registration Number: NCT01033682

Locations: 🇬🇧
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

The Physiological Response to Routine Head and Neck Cancer Surgery

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2009-12-15

Last Posted Date: 2016-05-23

Lead Sponsor: Royal Marsden NHS Foundation Trust

Target Recruit Count: 15

Registration Number: NCT01032096

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy